Covered recipient · General Payments record
JESSICA RAASCH
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2022
$236.69
- Reported across 14 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.08 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $46.57 | 2 |
| Teva Pharmaceuticals USA, Inc. | $24.18 | 1 |
| Amarin Pharma Inc. | $22.59 | 1 |
| Corcept Therapeutics | $20.63 | 1 |
| Novo Nordisk AS | $19.07 | 1 |
| ORGANOGENESIS INC. | $13.54 | 1 |
| ABBVIE INC. | $12.75 | 1 |
| Lilly USA, LLC | $11.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.75 | 10/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894058095 | CMS |
| Amarin Pharma Inc. | $22.59 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 913966823 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.40 | 07/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923919003 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.17 | 07/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923919005 | CMS |
| Corcept Therapeutics | $20.63 | 07/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 948804589 | CMS |
| Lilly USA, LLC | $11.75 | 08/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918562795 | CMS |
| Novo Nordisk Inc | $19.07 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899148149 | CMS |
| Organogenesis Inc. | $13.54 | 05/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 960113183 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.18 | 05/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954845735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.